2 gastrointestinal drugs get FDA approval

Two drugs treating gastrointestinal illnesses have received FDA approval, Phathom Pharmaceuticals said May 3. 

Voquezna Triple Pak and Voquezna Dual Pak both treat helicobacter pylori and are supplied in blister packs. 

A commercial launch is expected in the third quarter of 2022. 

 

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast